UnitedHealth Group (NYSE:UNH) had its price target hoisted by Wells Fargo & Co from $288.00 to $318.00 in a report released on Wednesday, The Fly reports. The firm currently has an in-line rating on the healthcare conglomerate’s stock.
UNH has been the subject of several other reports. UBS Group dropped their target price on UnitedHealth Group from $281.00 to $257.00 and set a neutral rating for the company in a report on Thursday, October 17th. Jefferies Financial Group lowered UnitedHealth Group from a buy rating to a hold rating and reduced their price target for the stock from $300.00 to $235.00 in a report on Thursday, October 10th. Deutsche Bank initiated coverage on shares of UnitedHealth Group in a research report on Thursday, September 12th. They set a hold rating and a $263.00 price target on the stock. Credit Suisse Group set a $293.00 price objective on shares of UnitedHealth Group and gave the company a buy rating in a report on Thursday, August 29th. Finally, Citigroup cut their price objective on shares of UnitedHealth Group from $299.00 to $286.00 and set a buy rating for the company in a research report on Wednesday, October 16th. Six investment analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company’s stock. The stock currently has an average rating of Buy and a consensus target price of $299.35.
Shares of UnitedHealth Group stock traded up $1.03 on Wednesday, hitting $280.35. 1,151,168 shares of the company were exchanged, compared to its average volume of 4,470,949. The company has a quick ratio of 0.70, a current ratio of 0.70 and a debt-to-equity ratio of 0.67. The company has a 50-day moving average price of $260.30 and a 200 day moving average price of $245.75. The stock has a market capitalization of $264.70 billion, a price-to-earnings ratio of 21.77, a price-to-earnings-growth ratio of 1.48 and a beta of 0.64. UnitedHealth Group has a 1-year low of $208.07 and a 1-year high of $283.00.
UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $3.88 EPS for the quarter, beating the consensus estimate of $3.75 by $0.13. UnitedHealth Group had a return on equity of 25.30% and a net margin of 5.57%. The firm had revenue of $60.35 billion during the quarter, compared to analysts’ expectations of $59.84 billion. During the same quarter last year, the firm earned $3.41 earnings per share. The business’s revenue for the quarter was up 6.7% on a year-over-year basis. Research analysts forecast that UnitedHealth Group will post 14.96 EPS for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Monday, December 9th will be given a dividend of $1.08 per share. This represents a $4.32 dividend on an annualized basis and a dividend yield of 1.54%. The ex-dividend date of this dividend is Friday, December 6th. UnitedHealth Group’s payout ratio is 33.54%.
In other UnitedHealth Group news, Director Richard T. Burke sold 2,500 shares of the stock in a transaction dated Thursday, September 19th. The shares were sold at an average price of $233.40, for a total transaction of $583,500.00. Following the completion of the transaction, the director now owns 187,979 shares of the company’s stock, valued at $43,874,298.60. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, CAO Thomas E. Roos sold 1,177 shares of the stock in a transaction dated Thursday, November 7th. The stock was sold at an average price of $255.04, for a total transaction of $300,182.08. Following the transaction, the chief accounting officer now directly owns 21,687 shares of the company’s stock, valued at approximately $5,531,052.48. The disclosure for this sale can be found here. Insiders have sold a total of 38,577 shares of company stock valued at $9,398,080 over the last three months. Corporate insiders own 0.82% of the company’s stock.
Institutional investors have recently added to or reduced their stakes in the company. Berkeley Capital Partners LLC grew its stake in shares of UnitedHealth Group by 7.4% in the second quarter. Berkeley Capital Partners LLC now owns 2,220 shares of the healthcare conglomerate’s stock valued at $542,000 after buying an additional 153 shares in the last quarter. Granite Investment Partners LLC lifted its stake in UnitedHealth Group by 1.8% during the 2nd quarter. Granite Investment Partners LLC now owns 67,540 shares of the healthcare conglomerate’s stock worth $16,480,000 after acquiring an additional 1,193 shares in the last quarter. Everence Capital Management Inc. lifted its stake in UnitedHealth Group by 5.1% during the 2nd quarter. Everence Capital Management Inc. now owns 18,890 shares of the healthcare conglomerate’s stock worth $4,609,000 after acquiring an additional 910 shares in the last quarter. Seeyond lifted its stake in UnitedHealth Group by 3.8% during the 2nd quarter. Seeyond now owns 10,299 shares of the healthcare conglomerate’s stock worth $2,513,000 after acquiring an additional 373 shares in the last quarter. Finally, Armstrong Shaw Associates Inc. CT boosted its holdings in UnitedHealth Group by 3.0% during the 2nd quarter. Armstrong Shaw Associates Inc. CT now owns 20,134 shares of the healthcare conglomerate’s stock valued at $4,913,000 after acquiring an additional 592 shares during the period. 85.50% of the stock is currently owned by institutional investors and hedge funds.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.